USANA Health Sciences (USNA) Peer Comparison
$14.40
$-0.17
(-1.13%)
As on 03-Sep-2026 10:32EDT
Market cap
$244 Mln
Revenue (TTM)
$913 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Edit
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
244 | 10,705 | 7,546 | 5,688 | 4,080 |
Revenue ($ Mln) |
913 | 6,555 | 18,436 | 1,086 | 10,272 |
Net Profit ($ Mln) |
-22.16 | 597.93 | 545.61 | 164.41 | 634.00 |
Net Margin (%) |
-2.43 | 9.12 | 2.96 | 15.14 | 6.17 |
RoE (%) |
-4.19 | 11.81 | 14.69 | 12.85 | 11.76 |
Price to Earnings |
-- | 17.99 | 13.84 | 35.13 | 6.45 |
Price-To-Book |
0.47 | 2.01 | 1.98 | 4.35 | 0.76 |
Income Statement ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
913.36 | 6,555.46 | 18,436.04 | 1,085.88 | 10,272.00 |
|
Cost of Revenue
|
206.00 | 4,913.84 | 16,662.83 | 691.76 | 9,455.00 |
|
Gross Profit
|
724.41 | 969.46 | 2,358.14 | 370.63 | 677.00 |
|
Operating Expenses
|
695.01 | 599.18 | 845.23 | 164.62 | 478.00 |
|
Operating Profit (EBIT)
|
12.35 | 1,042.44 | 927.99 | 229.50 | 339.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
2.54 | 743.25 | 789.73 | 212.38 | 607.00 |
|
Provision for Tax
|
31.79 | 136.99 | 244.06 | 47.97 | -32.00 |
|
Profit after Tax (Net Income)
|
-22.16 | 597.93 | 545.61 | 164.41 | 634.00 |
|
Minority Interest
|
-0.04 | -8.33 | -0.06 | 0.00 | -5.00 |
|
Consolidated Profit
|
0.00 | 76.30 | 0.00 | 0.00 | 362.00 |
Liabilities ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
526.31 | 5,245.73 | 3,749.85 | 1,302.38 | 5,486.00 |
|
Minority Interest
|
-0.04 | -8.33 | -0.06 | 0.00 | -5.00 |
|
Non-Current Liabilities
|
26.56 | 4,554.90 | 3,521.57 | 238.87 | 1,488.00 |
|
Current Liabilities
|
105.68 | 1,123.06 | 2,744.96 | 145.76 | 1,685.00 |
|
Total Liabilities
|
742.92 | 10,298.78 | 10,343.53 | 1,707.56 | 8,246.00 |
Assets ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
422.14 | 9,226.82 | 6,309.69 | 1,298.58 | 4,633.00 |
|
Current Assets
|
281.07 | 1,750.14 | 3,720.23 | 388.42 | 4,049.00 |
|
Total Assets
|
742.92 | 10,298.78 | 10,343.53 | 1,707.56 | 8,246.00 |
|
Total Debt*
|
0.00 | 4,171.20 | 3,052.10 | 166.72 | 1,595.00 |
|
Net Current Assets
|
0.00 | 634.33 | 975.28 | 0.00 | 2,364.00 |
Cashflow ($ Mln)
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
22.35 | 1,059.72 | 1,371.65 | 216.56 | 568.00 |
|
Cash Flow from Investing Activities
|
-10.13 | -720.28 | -705.51 | -43.89 | -543.00 |
|
Cash from Financing Activities
|
-40.60 | -337.89 | -2,113.00 | -152.81 | 44.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
1.92 | 0.72 | 14.69 | 11.03 | 7.31 |
|
ROE (%)
|
-4.19 | 11.81 | 14.69 | 12.85 | 11.76 |
|
ROA (%)
|
-2.41 | 5.12 | 4.28 | 8.45 | 6.43 |
|
EBIT Margin (%)
|
2.39 | 14.68 | 5.19 | 20.31 | 4.16 |
|
Net Margin (%)
|
-2.43 | 9.12 | 2.96 | 15.14 | 6.17 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
1.57 | 15.07 | 1.42 | 10.14 | 8.17 |
|
EBIT Growth (%)
|
-66.61 | 214.63 | -46.71 | 11.45 | 20.96 |
|
Net Profit Growth (%)
|
-164.91 | 467.52 | -55.90 | 15.18 | 356.12 |
|
EPS Growth (%)
|
-166.63 | 469.51 | -55.98 | 16.39 | 360.59 |
|
Book Value Growth (%)
|
-0.63 | 12.80 | 0.09 | 4.32 | 14.84 |
Valuation Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
33.39 | 91.95 | 8.59 | 32.01 | 8.64 |
|
Price / Book Value
|
0.67 | 1.22 | 2.53 | 3.94 | 0.82 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
2.62 | 12.42 | 5.67 | 19.94 | 8.04 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.73 | 0.76 | 0.00 | 0.18 |
|
Short term debt to equity ratio
|
0.00 | 0.03 | 0.00 | 0.00 | 0.11 |
|
Current Ratio
|
2.66 | 1.56 | 1.36 | 2.66 | 2.40 |
|
Quick Ratio
|
1.84 | 1.02 | 0.62 | 1.56 | 1.33 |
|
Interest Coverage
|
7.16 | 266.83 | 5.79 | 24.41 | 9.43 |
Operating Efficiency Ratios
| USANA Health Sciences (USNA) | Darling Ingredients (DAR) | Pilgrims Pride Corp (PPC) | Balchem Corporation (BCPC) | Seaboard (SEB) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.37 | 10.59 | 5.02 | 13.72 | 8.69 |
|
Asset Turnover
|
0.99 | 0.56 | 1.45 | 0.56 | 1.04 |
|
Receivable days
|
3.25 | 37.99 | 23.31 | 46.35 | 28.99 |
|
Inventory Days
|
156.70 | 39.01 | 43.17 | 71.86 | 58.82 |
|
Payable days
|
26.59 | 25.42 | 30.21 | 31.56 | 16.41 |
|
Cash Conversion Cycle
|
133.36 | 51.58 | 36.27 | 86.65 | 71.40 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
